CAPILLARY
Capillary Technologies India Limited (NSE: CAPILLARY) falls 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) stock price falls 5% intraday to ₹507.05, reflecting a breakdown in trendline status..
Capillary Technologies India Limited (CAPILLARY) fell -5% to ₹507.05 on the NSE on 28 Jul 2026, following the resignation of Mr. Sunil M Jain, Head – Corporate Development. The stock is now approaching resistance at ₹512, just 0.9% away, after breaking down from a 6-month trendline. Capillary Technologies, a player in the technology sector focused on software infrastructure, saw a company-specific move today, not aligned with broader sector momentum.
Technical setup — trendlines & DMA
The current trendline structure shows a breakdown from the 6-month support trendline, which ended at ₹491.98, with the stock now trading 2.97% above this level. Resistance is near at ₹511.86, just 0.95% above the current price. The 50-DMA at ₹504.1 is below the 200-DMA at ₹562.4, indicating a bearish trend. The stock is currently in the lower third of its 52-week range, suggesting that while there is room for upward movement, the recent decline has priced in some of the potential gains.
Snapshot: ₹507.05 on 2026-07-28 (chart frozen at publication)
Fundamentals & business context
With a PE of 78.0 and profit margins at 7.1%, Capillary Technologies is trading at a high valuation relative to its current earnings, though its revenue CAGR of 42.2% over the past five years suggests strong growth. The 20.6% institutional ownership indicates that smart money has a measured interest in the company, though not overwhelmingly bullish. There was no NSE catalyst today beyond the management change, which may have contributed to the sell-off.
Algorithmic scorecard
The overall score reflects a technically strong but fundamentally weaker position. The strongest signals include the excellent revenue CAGR of 42.2%, indicating robust growth, and the very low debt levels with a D/E of 0.00, showcasing excellent financial health. On the weaker side, the low profit margin of 7.1% leaves little room for error, and the negligible dividend yield of 0% offers little income to shareholders. These factors highlight the risk-reward balance investors face with Capillary Technologies.
Company outlook
Management expects revenues to cross INR 1,000-1,050 crores in FY27, driven by the SessionM acquisition and organic growth. They anticipate EBITDA margins to remain sustainable, with a steady-state target of 25-30%. The SessionM acquisition is expected to deliver significant revenue growth and EBITDA contributions in the coming years. Capillary plans to focus on a 115% NRR for the organic business and target upgrades on the inorganic side to improve margins. Additionally, they aim to develop an AI-led platform to upgrade customers from acquired stacks to Capillary, targeting margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.
Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to ₹530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at ₹512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level at ₹512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at ₹464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at ₹505.2, indicating an extended move. However, it is slightly below the 200-DMA at ₹560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.
Snapshot: ₹530.40 on 2026-08-10 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.
Company outlook
Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) gains 10% intraday, breaks out
Capillary Technologies India Limited (CAPILLARY) stock gains 10% intraday, breaking out from its 6M resistance trendline.
Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +10% to ₹589.4 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase and a 132% surge in adjusted EBITDA. This move is company-specific, driven by strong financial performance rather than sector-wide momentum. Capillary Technologies, a player in the technology sector focusing on software infrastructure, has shown remarkable growth, distinguishing itself from broader market trends.
Technical setup — trendlines & DMA
From a technical standpoint, CAPILLARY has cleared its 6-month resistance trendline, currently standing at ₹511.86, marking a breakout. The stock is now trading 13.16% above this resistance level, indicating strong upward momentum. The 6-month support trendline is at ₹466.56, which is 20.84% below the current price, providing a solid floor. The 50-day moving average (DMA) at ₹504.1 is below the 200-DMA at ₹561.1, suggesting a bearish trend in the short term but a bullish trend in the long term. CAPILLARY is currently in the middle third of its 52-week range, which spans from ₹464.2 to ₹799.0, implying there is room for further upside.
Snapshot: ₹589.40 on 2026-08-05 (chart frozen at publication)
Fundamentals & business context
Fundamentally, CAPILLARY presents a mixed picture. With a PE ratio of 78.0 and profit margins at 7.1%, the valuation appears stretched relative to current earnings, especially given the thin profit margins. However, the revenue CAGR of 42.2% over the past five years indicates strong growth potential. Institutional ownership stands at 20.6%, suggesting that smart money has a moderate level of confidence in the company. The recent NSE filing highlights a robust quarter with significant revenue and EBITDA growth, reinforcing the positive sentiment around the stock.
Algorithmic scorecard
The algorithmic scorecard reflects a technically strong but fundamentally weaker profile for CAPILLARY. The breakout above resistance and the bullish sentiment over the last 30 days, with an 8.57x higher average volume on up days compared to down days, signal strong accumulation and positive market sentiment. However, the low profit margin of 7.1% and the negligible dividend yield of 0% represent significant risks. The company’s excellent revenue growth consistency and very low debt level are strong positives, but the declining profit CAGR and lack of dividend income could be concerns for income-focused investors.
Company outlook
Management’s forward guidance for Capillary Technologies is optimistic, with expectations for EBITDA margins to remain sustainable, despite a potential dip due to the SessionM acquisition. The company anticipates core organic business margins to reach a steady-state of 25-30% EBITDA margin. Revenues are projected to exceed INR 1,000-1,050 crores in FY27, driven by both organic growth and the SessionM acquisition. SessionM is expected to significantly contribute to revenue and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to enhance margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) breaks out, gains 7% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) stock breaks out, gaining 7% intraday to ₹572.7, backed by strong Q1 FY2027 results.
Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +7% to ₹572.7 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase. This move is driven by the company’s strong financial performance, which has cleared its 6-month resistance trendline after a period of consolidation. Capillary Technologies, a player in the technology sector specializing in software infrastructure, has shown a company-specific surge rather than aligning with broader sector momentum.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level of ₹511.86, with the stock now trading 10.62% above this point. The 6-month support floor is at ₹466.56, which is 18.53% below today’s price, indicating a strong upward move. The 50-day moving average (DMA) is at ₹504.1, while the 200-DMA is at ₹561.1, showing that the stock is trading above the 50-DMA but still below the 200-DMA. This suggests a mixed position in terms of moving averages. The stock is currently in the lower third of its 52-week range, indicating that there may be room for further upside as it has only recovered 32% from its 52-week low.
Snapshot: ₹572.70 on 2026-08-05 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 78.0, Capillary Technologies is trading at a high valuation relative to its profit margin of 7.1%, which suggests that the market may be pricing in future growth rather than current earnings. The company’s revenue CAGR of 42.2% over the past five years indicates strong growth, but the absence of profit CAGR suggests that this growth has not yet translated into consistent profitability. The 20.6% institutional ownership reflects a cautious yet interested stance from the smart money, possibly indicating a balance between growth potential and risk. Today’s move is directly linked to the strong Q1 FY2027 results, which served as a clear catalyst.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weaker profile for Capillary Technologies. The strongest signals come from the breakout above resistance levels with momentum, indicating a positive technical setup, and the consistent revenue growth every year, which points to exceptional business stability. On the weaker side, the low profit margin of 7.1% leaves little room for error, and the negligible dividend yield offers little to no income for investors. These factors highlight the risk of thin profits and the lack of income generation through dividends.
Company outlook
Capillary Technologies has provided forward guidance indicating that revenues are expected to cross INR 1,000-1,050 crores in FY27, driven by the SessionM acquisition and organic growth. The company expects EBITDA margins to remain at sustainable levels, with a core organic business moving towards a steady-state EBITDA margin of 25-30%. SessionM is expected to deliver significant revenue growth and EBITDA contributions in the coming years. The company plans to maintain a focus on a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. Additionally, Capillary Technologies intends to develop an AI-led platform to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
-
ARVIND3 days agoArvind Limited (arvind) Inaugurates State-of-the-art Garment Manufacturing Facility in Varanasi
-
COFORGE2 days agoCoforge Limited (NSE: Coforge) Named Leader in Everest Group QE Services for AI Applications and Systems PEAK Matrix® Assessment 2026
-
Consumer Defensive2 days agoLt Foods Limited Launches Campaign for Rozana with Celebrity Chef Ranveer Brar
-
Healthcare2 days agoSudeep Pharma Limited (sudeepphrm) FDA Approval Enables New Pharma Greenfield Facility Operations
-
Conglomerates1 day agoDcm Shriram Limited (dcmshriram) Q2 FY27: 22% Revenue Growth at ₹3,977 Crore
-
Basic Materials1 day agoChemcon Speciality Chemicals Limited Q2 FY27: Revenue Up 22%, PAT Surges 31%
-
E2E1 day agoE2e Networks Limited Plans 5.4 MW Nvidia Blackwell Expansion of India’s AI Factory
-
Agricultural Inputs1 day agoAstec Lifesciences Limited (astec) Q2 FY27: Revenue Down, Ebitda Negative